{
    "clinical_study": {
        "@rank": "80765", 
        "arm_group": [
            {
                "arm_group_label": "phenylephrine 50mcg bolus", 
                "arm_group_type": "Experimental", 
                "description": "Phenylephrine 50 mcg bolus dosing with continuous placebo infusion"
            }, 
            {
                "arm_group_label": "Phenylephrine 100 mcg bolus", 
                "arm_group_type": "Experimental", 
                "description": "Phenylephrine 100 mcg bolus dosing wtih continuous placebo infusion."
            }, 
            {
                "arm_group_label": "Phenylephrine continuous infusion 100mcg/min", 
                "arm_group_type": "Experimental", 
                "description": "Continuous phenylephrine infusion of 100 mcg/min with placebo bolus dosing."
            }
        ], 
        "brief_summary": {
            "textblock": "Three different regimens of phenylephrine are being evaluated to see if one is superior over\n      the other in the maintenance of cardiac output while keeping normotension and/or treating\n      hypotension experienced when receiving spinal anesthesia for cesarean delivery."
        }, 
        "brief_title": "Phenylephrine Dose and Mode of Administration for Spinal Anesthesia Induced Hypotension", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Complications; Cesarean Section", 
            "Spinal Anesthetics Causing Adverse Effects in Therapeutic Use"
        ], 
        "condition_browse": {
            "mesh_term": "Hypotension"
        }, 
        "detailed_description": {
            "textblock": "Phenylephrine will be administered in one of 3 regimens:  Intermittent bolus of 50 mcg,\n      Intermittent bolus of 100 mcg, or continuous infusion of 100 mcg/min.  The infusion will\n      contain either phenylephrine or normal saline (placebo). Subjects who are randomized to\n      receive a bolus dose will receive placebo in the infusion.  Subjects who are randomized to\n      receive the phenylephrine infusion will have normal saline (placebo) in the bolus syringe.\n      Baseline blood pressures will be obtained prior to surgery and then maintained using these\n      drugs.  Blood pressure and heart rate will be monitored as usual standard of care.\n      Continuous cardiac output and hemodynamic monitoring will be obtained using CNAP (Tm) or\n      similar (equivalent) monitoring device.   Blood pressure will be maintained at 90-120% of\n      baseline utilizing infusion and/or bolus with the 3 regimens."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  scheduled for cesarean delivery age >/=18 years of age >/= 37 weeks EGA ASA status\n             I-III\n\n        Exclusion Criteria:\n\n          -  allergy to medications used in the study non-English speaking"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02101047", 
            "org_study_id": "IRB 26872"
        }, 
        "intervention": {
            "arm_group_label": [
                "phenylephrine 50mcg bolus", 
                "Phenylephrine 100 mcg bolus", 
                "Phenylephrine continuous infusion 100mcg/min"
            ], 
            "intervention_name": "Phenylephrine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Phenylephrine", 
                "Oxymetazoline"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cesarean section", 
            "hypotension", 
            "phenylephrine"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "last_name": "Peter Pan, MD", 
                "phone": "336-718-8278"
            }, 
            "contact_backup": {
                "last_name": "Lynnette Harris, BSN", 
                "phone": "336-718-6049"
            }, 
            "facility": {
                "address": {
                    "city": "Winston-Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27103"
                }, 
                "name": "Novant Health Forsyth Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Correlation and Effects on Cardiac Output With Intermittent Phenylephrine Administration of 50 mcg Versus 100 mcg or 100mcg/Min Prophylactic Infusion for Treatment of Hypotension in Parturients After Receiving Spinal Anesthesia for Cesarean Delivery", 
        "overall_contact": {
            "last_name": "Lynnette Harris, BSN", 
            "phone": "336-718-6049"
        }, 
        "overall_contact_backup": {
            "last_name": "Peter Pan, MD", 
            "phone": "336-718-8278"
        }, 
        "overall_official": {
            "affiliation": "Wake Forest School of Medicine", 
            "last_name": "Peter Pan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Magnitude of cardiac output reduction for the duration from preoperative baseline from time of spinal anesthesia to delivery of fetus and placenta.", 
            "measure": "Magnitude of cardiac output changes", 
            "safety_issue": "Yes", 
            "time_frame": "0-90 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02101047"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wake Forest School of Medicine", 
            "investigator_full_name": "Dr. Peter H. Pan, M.D., MSEE", 
            "investigator_title": "Professor of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "number of provider intervention to treat abnormal hemodynamics", 
                "measure": "provider intervention", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "description": "total amount of vasopressor or equivalent required", 
                "measure": "vasopressor requirement", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "description": "emetic symptoms - magnitude and/or incidence", 
                "measure": "Emetic symptoms", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "description": "incidence and magnitude", 
                "measure": "hypertension", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "description": "incidence and magnitude", 
                "measure": "hypotension", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "description": "incidence and magnitude", 
                "measure": "bradycardia", 
                "safety_issue": "Yes", 
                "time_frame": "0-90 minutes"
            }, 
            {
                "measure": "Anesthetic time", 
                "safety_issue": "Yes", 
                "time_frame": "up to 120 minutes"
            }
        ], 
        "source": "Wake Forest School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wake Forest School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}